A study has shown that soluble fms-like tyrosine kinase (sFlt-1)/placental growth factor (PlGF) ratio, already used for assessing preeclampsia, helps identify women with the condition who are at risk for imminent delivery. Read more.
Test helps identify preeclampsia women at risk for imminent delivery
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
